Mirapex (pramipexole) will be the first drug approved to treat restless legs syndrome

Mirapex (pramipexole) will be the first drug approved to treat restless legs syndrome in Canada.

Restless legs syndrome affects about 5% to 15% of the population. Patients usually have tingling in their legs at rest, along with an irresistible urge to move the legs.

About 90% have problems getting to sleep and falling asleep.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote